2023 Outstanding Achievement in Clinical Diabetes Research Award
Silva Arslanian, MD
Silva Arslanian, MD, is Professor of Pediatrics, and Professor of Clinical and Translational Science Institute at the University of Pittsburgh, School of Medicine. She holds the Richard L. Day Endowed Chair in Pediatrics at the UPMC Children’s Hospital of Pittsburgh. She is the Director of the Pediatric Clinical and Translational Research Center of the NIH-funded CTSI, and the Director of the Center for Pediatric Research in Obesity & Metabolism at the UPMC Children's Hospital.
Dr. Arslanian obtained her medical degree from the American University of Beirut and completed her pediatric residency training at the same institution. She completed her fellowship in Pediatric Endocrinology at the UPMC Children’s Hospital of Pittsburgh.
Dr. Arslanian is funded by NIH, Research Foundations and Pharmaceutical Companies. Her research focus is insulin sensitivity and beta cell function during childhood growth and development, in health and disease (prediabetes, Type 2 diabetes, obesity, cardiometabolic syndrome, PCOS), and racial disparities in the aforementioned. Her patient-oriented research provided breakthroughs in discerning the pathophysiology of youth type 2 diabetes, the rapid deterioration in b-cell function and therapeutic options. She was a key player in landmark trials including TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) and RISE (Restoring Insulin SEcretion). She has served the national and international scientific communities in various educational and advisory capacities. Dr. Arslanian has more than 250 publications and is the recipient of several prestigious awards for her seminal contributions in advancing scientific discoveries in youth type 2 diabetes, childhood insulin resistance and beta cell function.
Please join us in celebrating Silva Arslanian, MD, for remarkable contributions that have substantially influenced the clinical care of diabetes.